Contact us
Log in
Servier

Servier

Overview

Servier is a global pharmaceutical group governed by a Foundation. Relying on a solid geographical presence and revenue of €4.7 billion in 2020 achieved in 150 countries, Servier employs 22,500 people worldwide. Servier is an independent group that invests over 20% of its brand-name revenue in Research and Development every year. To accelerate therapeutic innovation for the benefit of patients, the Group is committed to open and collaborative innovation with academic partners, pharmaceutical groups, and biotech companies. It also integrates the patient’s voice at the heart of its activities, from research to support beyond the pill.


A leader in cardiology, the ambition of the Servier Group is to become a recognized and innovative player in oncology. Its growth is based on a sustained commitment to cardiovascular and metabolic diseases, oncology and immuno-inflammatory, and neuropsychiatric diseases. To promote access to healthcare for all, the Servier Group also offers a range of quality generic drugs covering most pathologies.


Find out more on : www.servier.com.

Suresnes, Île-de-France, France
24 Faculty
4 Courses available
512 Reviews

On-demand

Replay-Modern Type 2 Diabetes Care: Why SUs remain a cornerstone (3:00-4:30 PM)
Endocrinology - Diabetology - Nutrition
Online
Replay
4.6
Replay-Modern Type 2 Diabetes Care: Why SUs remain a cornerstone(10:00-11:30 AM)
Endocrinology - Diabetology - Nutrition
Online
Replay
4.6
Repetición - Tratamiento actual de la diabetes tipo 2: Por qué las sulfonilureas siguen siendo fundamentales?
Endocrinology - Diabetology - Nutrition
Online
E-learning
4.6
REPLAY - Modern type 2 diabetes care : Why sulfonylureas (SUs) remain a cornerstone (Africa Session)
Endocrinology - Diabetology - Nutrition
Online
E-learning
4.6

Faculty

Overview

Head of Department Diabetes Research Centre University of Leicester, Leicester, United Kingdom

Professor of Primary Care Diabetes and Vascular Medicine at the University of Leicester, UK. Prof Kamlesh Khunti is Co-Director of the Leicester Diabetes Centre and leads a research group that is currently working on the early identification of, and interventions with, people who have cardiometabolic disease or who are at increased risk of developing cardiometabolic diseases. His work has influenced national and international guidelines on the screening and management of people with diabetes. Professor Khunti is also Director of the UK National Institute for Health Research (NIHR) in Applied Research Collaborations (ARC) East Midlands and Director of The Real-World Evidence Unit and Centre for BME Health. He is a NIHR Senior Investigator and Principal Investigator on several major national and international studies. He is the National NIHR ARC Theme Lead for Multimorbidity and Ethnicity and Diversity. He is also Honorary Visiting Professorial Fellow at the Department of General Practice, University of Melbourne, Australia.

Dr. Mohamed HASSANEIN
Chair of Diabetes and Ramadan International Alliance
Overview

MB ChB, FRCP-Lon, FRCP-Edin, MPhil, CCST

Dubai Hospital, Dubai Health Authority, UAE

H Prof of Medicine, Gulf Medical University, UAE

Cardiff University School of Medicine, Cardiff, UK

Chair of Diabetes and Ramadan International Alliance

He the first author or a co-author in almost 80 papers in various topics particularly diabetes and Ramadan where he co-authored recommendations on this subject for the IDF in 2016, ADA in 2005 & 2010, and for the BMJ in 2010 and presented on numerous occasions at international meetings. He also developed 3 educational programs for diabetes and Ramadan in collaboration with various international centres. He is a co-recipient of the Diabetes–UK Structured Education first prize in 2008 and 2009 as well as the European Association for the Study of Diabetes (EASD) education prize in 2009.

Dr Hassanein has also helped develop various national and international Guidelines and is an examiner with the Royal College of Physicians for the MRCP clinical exam. He has been closely associated with a number of educational projects in many regions. He’s the associate editor for Diabetes Research and Clinical Practice Journal as well as Dubai Diabetes and Endocrinology Journal

Overview

Professor Nemencio A. Nicodemus Jr. trained in Internal Medicine and Adult Endocrinology at the Philippine General Hospital. Currently, he works in the Department of Biochemistry & Molecular Biology in the University of the Philippines, College of Medicine. He is also a Clinical Professor in the Department of Medicine, Division of Endocrinology, Diabetes & Metabolism at the Philippine General Hospital

Dr. Aslam Amod
Endocrinologist - Fellow of the College of Physicians in South Africa
Overview

Dr Aslam Amod graduated at the University of Natal in 1988 and is a Fellow of the College of Physicians in South Africa as well as the Royal College of Physicians in London. He is certified in the sub-speciality of Endocrinology and Metabolism.

He is an endocrinologist in private practice at the Life Chatsmed Garden Hospital, and is also a lecturer at the Department of Diabetes and Endocrinology, University of Kwa Zulu Natal. He has also been a past lecturer at the Cardiff University School of Medicine in Wales.

Aslam has always been actively involved in clinical and academic medicine, clinical research and medical education for the past 30 years. He lectures widely in the field of endocrinology, has presented at local and international congresses, and has published more than 45 articles in local and international journals. He has served as an executive member and chairperson of many medical societies. Currently he is an executive member of The Faculty of Consulting Physicians of South Africa as well as The Society of Endocrinology, Metabolism and Diabetes of South Africa [SEMDSA]. Aslam is also the chairman and chief editor for the (SEMDSA) Type 2 Diabetes Guidelines for South Africa since 2011.

Reviews

Global Review
4.6 /5
Pedagogy
4.5 /5
Organisation
4.6 /5
Knowledge aquired
4.5 /5
Recommendation
4.7 /5
Nov 30, 2021
Jacob C.
Nov 29, 2021
HADDAD R.
Nov 28, 2021
yamina k.
Nov 28, 2021
Zohra D. Satisfaite
Nov 28, 2021
Alexis M. Je vous remercie pour la présentation et j'ai vraiment appris avec vous et j'ai apprécié aussi la façon que les orateurs nous transmis.❣️
Nov 28, 2021
Asmae M. Organisation : Top notamment sur le plan technique Contenu interessant vu notre contexte maghrébin et africain Plusieurs avancées scientifiques interessantes malheureusement étranglées par le niveau socioeconomique de tout le continent africain?

Videos